Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Janssen withdraws antihistamine astemizole from the market

June 22, 1999

Antagonists of P2Y2 receptors designed at Astra (AstraZeneca)

June 22, 1999

Selective, stable and peripherally acting alpha2-adenoceptor agonists patented by P&G

June 21, 1999

Schering-Plough discloses oximes with neurokinin-antagonist activity

June 21, 1999

International patent covers new Schering-Plough antiallergic agents

June 18, 1999

Elastase inhibitor UT-77 in active development at United Therapeutics

June 18, 1999

RPR research group prepares new cell adhesion inhibitors especially useful in asthma

June 17, 1999

FDA grants orphan drug designation to PPL's AAT for congenital deficiency

June 16, 1999

Schering-Plough prepares potent H3 antagonists for allergy, CNS disorders, etc.

June 16, 1999

Chemokine peptides designed at NeoRx useful for inflammatory disorders

June 15, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
Anle-138b reduces mHTT aggregation, improves pathological phenotypes in Huntington’s models
BioWorld Science
Anle-138b (emrusolmin) is a diphenylpyrazole compound that directly interacts with oligomeric species of disease-related aggregating proteins, reducing aggregate...